Scott Gleason | VP of IR |
Mark Capone | CEO, President |
Bryan Riggsbee | Executive VP, CFO & Treasurer |
Steve Beuchaw | Morgan Stanley |
Doug Schenkel | Cowen & Company |
Patrick Donnelly | Goldman Sachs |
Puneet Souda | SVB Leerink Partners |
Bill Quirk | Piper Jaffray |
Tycho Peterson | JPMorgan |
Jack Meehan | Barclays |
Derik De Bruin | Bank of America Merrill Lynch |
Dan Leonard | Deutsche Bank |
Sung Ji Nam | BTIG |
Ladies and gentlemen, thank you for standing by, and welcome to the Myriad Genetics Second Quarter 2019 Financial Earnings Call. [Operator Instructions] This call is being recorded Tuesday, February 5, 2019. And now I'd like to turn the conference over to Scott Gleason, Vice President, Investor Relations, Myriad Genetic Laboratories. Please go ahead.
Thanks, Scott.